AAM
REGN icon

Augustine Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Augustine Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.29M Buy
6,884
+2,405
+54% +$1.64M 0.87% 24
2026
Q1 		$3.46M Buy
4,479
+8
+0.2% +$6.13K 0.78% 26
2025
Q4 		$3.45M Sell
4,471
-6
-0.1% -$4.08K 0.69% 24
2025
Q3 		$2.52M Sell
4,477
-31
-0.7% -$17.5K 0.51% 30
2025
Q2 		$2.37M Buy
4,508
+39
+0.9% +$21.8K 0.63% 27
2025
Q1 		$2.83M Sell
4,469
-5
-0.1% -$3.44K 0.83% 25
2024
Q4 		$3.19M Sell
4,474
-68
-1% -$57.1K 0.84% 22
2024
Q3 		$4.77M Sell
4,542
-14
-0.3% -$15.6K 1.67% 15
2024
Q2 		$4.79M Buy
4,556
+21
+0.5% +$20.4K 1.85% 13
2024
Q1 		$4.36M Sell
4,535
-11
-0.2% -$10.5K 1.82% 13
2023
Q4 		$3.99M Buy
4,546
+214
+5% +$176K 1.77% 17
2023
Q3 		$3.57M Sell
4,332
-136
-3% -$107K 1.65% 14
2023
Q2 		$3.21M Sell
4,468
-10
-0.2% -$7.71K 1.48% 17
2023
Q1 		$3.68M Sell
4,478
-26
-0.6% -$19.6K 1.82% 15
2022
Q4 		$3.25M Sell
4,504
-93
-2% -$68.6K 1.8% 17
2022
Q3 		$3.17M Buy
4,597
+4
+0.1% +$2.52K 2.08% 15
2022
Q2 		$2.71M Sell
4,593
-372
-7% -$242K 1.67% 20
2022
Q1 		$3.47M Sell
4,965
-11
-0.2% -$6.96K 1.74% 18
2021
Q4 		$3.14M Buy
4,976
+41
+0.8% +$25.2K 1.54% 22
2021
Q3 		$2.99M Sell
4,935
-107
-2% -$66.4K 1.59% 22
2021
Q2 		$2.82M Sell
5,042
-211
-4% -$107K 1.45% 23
2021
Q1 		$2.48M Buy
5,253
+39
+0.7% +$19K 1.31% 26
2020
Q4 		$2.52M Sell
5,214
-14
-0.3% -$7.56K 1.31% 27
2020
Q3 		$2.93M Sell
5,228
-356
-6% -$216K 1.72% 20
2020
Q2 		$3.48M Buy
5,584
+2,218
+66% +$1.26M 2.1% 16
2020
Q1 		$1.64M Buy
+3,366
New +$1.39M 1.17% 26

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Augustine Asset Management's REGN Position: Q2 2026 in Review

Augustine Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 54% in Q2 2026, buying an estimated $1.64M and bringing the position to 6,884 shares worth $4.29M. The position accounts for 0.87% of the portfolio, ranked #24.

Augustine Asset Management first reported a position in REGN in Q1 2020 and has held it in 26 quarters since. The position peaked at $4.79M in Q2 2024. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Augustine Asset Management held 6,884 shares of Regeneron Pharmaceuticals worth $4.29M as of Q2 2026.
  • Augustine Asset Management bought 2,405 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.64M.
  • Regeneron Pharmaceuticals made up 0.87% of Augustine Asset Management's portfolio in Q2 2026, its #24 holding.
  • Augustine Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Augustine Asset Management's Regeneron Pharmaceuticals position peaked at $4.79M in Q2 2024.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Augustine Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.